This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Galena Biopharma Inc (GALE)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 47.79M 32.81M 11.43M 6.89M
Receivables 3.68M 0.00 0.00 0.00
Inventories 386.00K 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 53.46M 36.12M 11.81M 7.04M
Property, Plant & Equipment, Gross 665.00K 48.00K 1.05M 910.00K
Accumulated Depreciation & Depletion 0.00 19.00K 657.00K 491.00K
Property, Plant & Equipment, Net 665.00K 29.00K 393.00K 419.00K
Intangibles 27.84M 12.86M 12.86M 0.00
Other Non-Current Assets 115.00K 74.00K 3.00K 16.00K
Total Non-Current Assets 34.52M 18.86M 19.16M 435.00K
Liabilities & Shareholder Equity
Total Assets 87.98M 54.99M 30.97M 7.48M
Accounts Payable 2.66M 1.98M 2.16M 724.00K
Short Term Debt 2.16M 6.00K 35.00K 51.00K
Other Current Liabilities 48.96M 11.90M 5.53M 3.14M
Total Current Liabilities 62.45M 15.92M 11.20M 5.03M
Long Term Debt 7.74M 0.00 0.00 0.00
Deferred Income Taxes 5.05M 5.05M 5.05M 0.00
Other Non-Current Liabilities 6.82M 6.21M 4.57M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 19.64M 11.31M 9.65M 20.00K
Total Liabilities 82.09M 27.23M 20.86M 5.05M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 5.89M 27.76M 10.11M 2.43M
Common Par 10.00K 8.00K 5.00K 2.00K
Additional Paid In Capital 188.60M 132.17M 81.18M 62.02M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -178.88M -102.20M -67.23M -55.74M
Treasury Stock -3.85M -3.85M -3.85M -3.85M
Other Equity Adjustments 0.00 1.63M 0.00 0.00
Total Capitalization 13.63M 27.76M 10.11M 2.43M
Total Equity 5.89M 27.76M 10.11M 2.43M
Total Liabilities & Stock Equity 87.98M 54.99M 30.97M 7.48M
Total Common Shares Outstanding 109.43M 82.92M 47.14M 18.37M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 675.00K 675.00K 675.00K 675.00K
Basic Weighted Shares Outstanding 90.18M 62.48M 36.33M 17.88M
Diluted Weighted Shares Outstanding 90.18M 62.48M 36.33M 17.88M
Number of Employees 60 12 29 32
Number of Part-Time Employees 0 0 0 0
GALE News

GALE Galena Biopharma Inc

Analysts Ratings for GALE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 5 5
Moderate Buy 1 1 1 1
Hold 1 1 0 0
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET GALE ANALYST REPORT

Brokerage Partners

GALE Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs